ClinicalTrials.Veeva

Menu

Analgesia After Video-Assisted Thoracic Surgery

A

Assiut University

Status and phase

Completed
Phase 2

Conditions

Post Operative Pain

Treatments

Drug: Ultrasound-guided thoracic paravertebral block with isobaric bupivacaine
Drug: Local wound infiltration with isobaric bupivacaine
Drug: Ultrasound-guided deep serratus anterior plane block with isobaric bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT05094323
10 2021

Details and patient eligibility

About

Although less invasive, postoperative analgesia remains challenging in patients undergoing uniportal video-assisted thoracic surgery (VATS).

Full description

Although less invasive, postoperative analgesia remains challenging in patients undergoing uniportal video-assisted thoracic surgery (VATS).

Adequate postoperative pain relief is imperative to hasten functional recovery, accelerate discharge from the hospital, and reduce chronic postsurgical pain.

Enrollment

102 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled for uniportal VATS under general anesthesia, ASA status I-III, aged from 18 to 70 years old of both sex.

Exclusion criteria

  • Contraindications to regional block
  • Pregnancy
  • Body mass index (BMI) > 30 Kg/m2
  • Psychiatric diseases
  • Severe renal, liver, or cardiac dysfunction

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

102 participants in 3 patient groups, including a placebo group

Group I
Active Comparator group
Description:
Patients will receive ultrasound-guided deep serratus anterior plane block.
Treatment:
Drug: Ultrasound-guided deep serratus anterior plane block with isobaric bupivacaine
Group II
Active Comparator group
Description:
Patients will receive local wound infiltration (LWI).
Treatment:
Drug: Local wound infiltration with isobaric bupivacaine
Group III
Placebo Comparator group
Description:
Patients will receive ultrasound-guided thoracic paravertebral block.
Treatment:
Drug: Ultrasound-guided thoracic paravertebral block with isobaric bupivacaine

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed K Fathy, Msc; Seham M Moeen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems